載入中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新資料
US$5.33
−US$0.22 · -3.96%
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
前收盤價
US$5.33
−US$0.22 · -3.96%
盤中時間採用ET。市場資料可能有所延遲。
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
日內區間
目前US$5.33
52週區間
目前US$5.33
盤中時間採用ET。市場資料可能有所延遲。
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
日內區間
目前US$5.33
52週區間
目前US$5.33
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 銷貨成本 | — | — | — | 5972 USD | 6.08萬 USD |
| 毛利 | — | — | — | −5972 USD | −6.08萬 USD |
| 研究與開發 | 405.48萬 USD | 361.88萬 USD | 351.71萬 USD | 104.74萬 USD | 102.18萬 USD |
| 銷售、一般及管理費用 | 786.2萬 USD | 407.74萬 USD | 237.53萬 USD | 129.05萬 USD | 72.12萬 USD |
| 營業費用 | 1191.68萬 USD | 769.62萬 USD | 589.24萬 USD | 233.79萬 USD | 168.22萬 USD |
| 利息收入 | 1090 USD | 3.81萬 USD | 7.91萬 USD | — | — |
| 利息支出 | 7.08萬 USD | 136.02萬 USD | 259.53萬 USD | 67.06萬 USD | 5.08萬 USD |
| 折舊和攤銷 | 29.01萬 USD | 5463 USD | 6811 USD | 5972 USD | 6.08萬 USD |
| 營業利益 | −1191.68萬 USD | −769.62萬 USD | −589.24萬 USD | −234.38萬 USD | −174.3萬 USD |
| 淨利 | −1172.17萬 USD | −914.48萬 USD | −659.27萬 USD | −499.61萬 USD | −115.21萬 USD |
公司資料更新於 2026年10月11日。
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
